Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026)
Labcorp Holdings' (LH) quarterly Cash from Financing Activities came in at -$919.9 million in Q2 2026, down 244.02% year-over-year from $638.7 million in Q2 2025, and down 258.47% quarter-over-quarter from $580.5 million in Q1 2026.
Analysis
Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$919.9 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 244.02% year-over-year to -$919.9 million; the TTM figure through Jun 2026 stood at -$689.3 million (down 553.36% YoY), while the FY2025 annual figure was -$1.5 billion, down 286.82% from the prior year.
- Cash from Financing Activities came in at -$919.9 million for Q2 2026 at Labcorp Holdings, down from $580.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.5 billion in Q3 2024 to a low of -$1.9 billion in Q4 2023.
- Average Cash from Financing Activities over 5 years is -$216.5 million, with a median of -$278.9 million recorded in 2025.
- Year-over-year, Cash from Financing Activities jumped 422.08% in 2023 and slumped 7076.92% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$372.6 million in 2022, then slumped by 422.33% to -$1.9 billion in 2023, then jumped by 71.91% to -$546.7 million in 2024, then jumped by 46.88% to -$290.4 million in 2025, then sank by 216.77% to -$919.9 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$919.9 million in Q2 2026, $580.5 million in Q1 2026, and -$290.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 12.21 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | -229.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -919.90 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 23.01 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 97.12 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -36.90 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | -2.41 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 6.09 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 142.19 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 4.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -919.90 Mn |
| Mar 31, 2026 | 580.50 Mn |
| Dec 31, 2025 | -290.40 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Jun 30, 2025 | -267.40 Mn |
| Mar 31, 2025 | -839.70 Mn |
| Dec 31, 2024 | -546.70 Mn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | -210.00 Mn |
| Mar 31, 2024 | -11.70 Mn |
| Dec 31, 2023 | -1.95 Bn |
| Sep 30, 2023 | -1.10 Bn |
| Jun 30, 2023 | 1.55 Bn |
| Mar 31, 2023 | -60.60 Mn |
| Dec 31, 2022 | -372.60 Mn |
| Sep 30, 2022 | -452.20 Mn |
| Jun 30, 2022 | -479.70 Mn |
| Mar 31, 2022 | -17.70 Mn |
| Dec 31, 2021 | -1.01 Bn |
| Sep 30, 2021 | -281.70 Mn |